Sphera Funds Management Ltd. Iovance Biotherapeutics, Inc. Transaction History

Sphera Funds Management Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$12.38 - $19.1 $3.49 Million - $5.38 Million	-281,769 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$16.55 - $27.63 $3.53 Million - $5.89 Million	-213,040 Reduced 43.05%	281,769 $5.38 Million
Q3 2021 Nov 15, 2021	BUY	$20.35 - $26.63 $2.36 Million - $3.09 Million	116,167 Added 30.68%	494,809 $12.2 Million
Q2 2021 Aug 17, 2021	BUY	$16.33 - $33.07 $6.18 Million - $12.5 Million	378,642 New	378,642 $9.85 Million
Q1 2021 May 17, 2021	SELL	$28.67 - $52.59 $3.65 Million - $6.69 Million	-127,289 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$28.04 - $50.26 $3.52 Million - $6.32 Million	-125,711 Reduced 49.69%	127,289 $5.91 Million
Q3 2020 Nov 12, 2020	SELL	$27.75 - $36.3 $2.64 Million - $3.45 Million	-95,000 Reduced 27.3%	253,000 $8.33 Million
Q2 2020 Aug 13, 2020	BUY	$27.21 - $41.0 $9.47 Million - $14.3 Million	348,000 New	348,000 $9.55 Million

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.35B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.